Company Analysis Kissei Pharmaceutical Co., Ltd.
1. Summary
Advantages
- Dividends (3.48%) are higher than the sector average (2.87%).
- The stock's return over the last year (24.08%) is higher than the sector average (6.13%).
- Current debt level 0.5135% is below 100% and has decreased over 5 years from 1.73%.
- The company's current efficiency (ROE=5.39%) is higher than the sector average (ROE=1.13%)
Disadvantages
- Price (3890 Β₯) is higher than fair price (3773.79 Β₯)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Kissei Pharmaceutical Co., Ltd. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0.1% | 0% | 0.3% |
| 90 days | 7% | 6.1% | 3.3% |
| 1 year | 24.1% | 6.1% | -1.6% |
4547 vs Sector: Kissei Pharmaceutical Co., Ltd. has outperformed the "Healthcare" sector by 17.95% over the past year.
4547 vs Market: Kissei Pharmaceutical Co., Ltd. has outperformed the market by 25.67% over the past year.
Stable price: 4547 is not significantly more volatile than the rest of the market on "Tokyo Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 4547 with weekly volatility of 0.4631% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (3890 Β₯) is higher than the fair price (3773.79 Β₯).
Price is higher than fair: The current price (3890 Β₯) is 3% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (14.3) is lower than that of the sector as a whole (112.46).
P/E vs Market: The company's P/E (14.3) is lower than that of the market as a whole (138.33).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (0.7214) is lower than that of the sector as a whole (70.29).
P/BV vs Market: The company's P/BV (0.7214) is lower than that of the market as a whole (107.9).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.11) is lower than that of the sector as a whole (75.53).
P/S vs Market: The company's P/S indicator (2.11) is lower than that of the market as a whole (108.73).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (7.37) is lower than that of the sector as a whole (29.26).
EV/Ebitda vs Market: The company's EV/Ebitda (7.37) is lower than that of the market as a whole (109.28).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 59.15% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (59.15%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-1.09%).
5.4. ROE
ROE vs Sector: The company's ROE (5.39%) is higher than that of the sector as a whole (1.13%).
ROE vs Market: The company's ROE (5.39%) is lower than that of the market as a whole (9.37%).
5.5. ROA
ROA vs Sector: The company's ROA (4.63%) is higher than that of the sector as a whole (0.6587%).
ROA vs Market: The company's ROA (4.63%) is higher than that of the market as a whole (4.45%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (7.28%) is lower than that of the sector as a whole (9.07%).
ROIC vs Market: The company's ROIC (7.28%) is lower than that of the market as a whole (8.75%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 3.48% is higher than the average for the sector '2.87%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 3.48% has been steadily paid over the past 7 years, DSI=0.86.
Weak dividend growth: The company's dividend yield 3.48% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (33.35%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
